Home | Articles
Published on:October 2021
Indian Journal of Pharmaceutical Education and Research |, 2021; 55(4):xx-xx
Original Article | doi:

Synthesis, Characterization and Antidiabetic Evaluation of Sulfonamide in Corporated with 1,3,4-Oxadiazole Derivatives


Authors and affiliation (s):

Megha Tukaram Salve*, Shailaja Bhanudas Jadhav Sr

Department of Pharmaceutical Chemistry of Modern College of Pharmacy, Nigdi, Pune, Maharashtra, INDIA.

Abstract:

ABSTRACT

Aim/Background: There is an increasing prevalence of diabetes mellitus throughout the world, and new compounds are necessary to combat this. While the current available antidiabetic therapies are long-term complicated and side effects-prone, this has led to a demand for more affordable, more effective methods of tackling diabetes. Research is focused on finding alternative medicinal remedies with significant antidiabetic efficacy as well as low adverse effects. This study synthesized, characterized, and evaluated anti-diabetic properties of synthetic sulphonamide hybrid of 1,3,4-oxadiazole derivatives.Materials and Methods: An invivo antihyperglycemic evaluation of the sulphonamide hybrid of 1,3,4-oxadiazole derivatives was conducted using wistar rat models of type II diabetes derived from a two-step synthesis. Our study examined the effects of synthesized compounds on a model induced by a high-fat diet combined with streptozotocin and nicotinamide injection. For assessment of diabetic effects, Vildagliptin (10 mg/kg/day) was used as the standard drug. On day 14th, 1,3,4-oxadiazole derivatives (50 mg/kg/day) significantly lowered the blood sugar of hyperglycemic rats. Results: Due HFD STZ with Nicotinamide blood glucose level of wistar rat was increased (295 ± 8.2). After 14th day administration of derivatives random blood glucose level under controlled. A-III (220± 7.5 B) and A-IV (222 ± 3.62 B) were lowered random blood glucose levels on wistar rat. As compared to diabetes control (295 ± 8.5), derivatives of 1,3,4-oxadiazole are considered promising lead compounds. Compounds A-III and A-IV were found to be the most effective in lowering blood glucose, indicating the potential of these compounds as antidiabetic agents. Conclusion: Hybrids developed in this study provide new classes of anti-diabetic agents, and further optimization can be performed using this information.

Key words: In vivo study, 1,3,4-Oxadiazole, Sulfonamide derivative, anti-diabetic agents.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs